Erratum: Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand (Nature medicine (2000) 6 (1167-1175))

B. Bielekova, B. Goodwin, N. Richert, I. Cortese, T. Kondo, G. Afshar, B. Gran, J. Eaton, J. Antel, J. A. Frank, H. F. McFarland, R. Martin

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)1412
Number of pages1
JournalNature Medicine
Volume6
Issue number12
DOIs
StatePublished - 2000
Externally publishedYes

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Bielekova, B., Goodwin, B., Richert, N., Cortese, I., Kondo, T., Afshar, G., Gran, B., Eaton, J., Antel, J., Frank, J. A., McFarland, H. F., & Martin, R. (2000). Erratum: Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand (Nature medicine (2000) 6 (1167-1175)). Nature Medicine, 6(12), 1412. https://doi.org/10.1038/82242